Thomas's campus, London; the 2Department of Rheumatology, The London Hospital; and the 3Department of Biological Sciences, Queen Mary College, London SUMMARY Rheumatoid sera and plasma inhibited the adherence of normal blood polymorphonuclear cells (PMNs) to cultured porcine endothelium. This inhibition of adhesion was not seen when PMNs were treated with the plasma or serum from normal subjects or patients with other inflammatory arthropathies. The abrogation of PMN adherence was directly related to the levels of circulating immune complexes and was not dependent upon the type of anti-inflammatory therapy that the patients were receiving nor on any of the recorded clinical parameters. A similar inhibition of adhesion was seen with heat induced aggregated human IgG (HAGG) provided that serum was present in the culture medium. In view of these results we propose that circulating immune complexes in RA may have a significant role in controlling the interaction of PMNs with vascular endothelium and in perpetuating the entry of these cells into the synovial fluid of the inflamed joints.
In the preceding paper it was shown that rheumatoid sera inhibited the adherence of normal blood polymorphonuclear cells (PMNs) to monolayers of porcine endothelium. ' The adherence of normal PMNs to nylon fibre columns is reported to be enhanced when the cells are suspended in the plasma, but not the serum, of patients with acute inflammatory disease2 and inhibited by the sera of patients receiving anti-inflammatory therapy. 3 To characterise the inhibitory factor present in RA blood, samples of plasma and serum were prepared from patients with RA, whose clinical presentations were carefully recorded. Similar samples were obtained from patients with other inflammatory arthropathies and normal subjects. The adherence modifying activities of these plasma/serum samples were tested in a quantitative monolayer adhesion assay and screened for evidence of immunological abnormalities. After the observation that an inhibition of PMN adherence by the RA samples correAccepted for publication 11 August 1986. Correspondence to Dr The final cell pellet was resuspended in 5 ml EMEM (Eagle's minimum essential medium) supplemented with 1 mM glutamine, 200 U/ml penicillin, and 100 U/ml streptomysin, buffered to pH 7-3 with 10 mM HEPES buffer (N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid) and filtered through 4 mm metal gauze to remove any large clumps. The viability of PMNs as assessed by trypan blue exclusion was >96%, and the cell concentration was adjusted to 1 X 106 cells/ml.
PREPARATION OF ENDOTHELIAL

MONOLAYERS
The method was identical to that described in the preceding paper' except that the final seeding of endothelial cells in the multiwell plates was onto the floor of each chamber and not onto glass coverslips. The mean (SD) percentage adherence for normal PMNs cocultured with 20% RA serum was 37 (10)%, which was lower (p<0 01) than the mean (45 (7)%) for PMNs cultured with serum from either normal subjects or patients with other inflammatory arthropathies (OIA). When 20% plasma was used in place of serum this inhibition was more marked (Fig. 2) . With RA plasma there was a mean 22 (11)% PMN adhesion in contrast with means of 38 (7)% and 48 (13)% PMN adhesion induced by plasma from subjects with OIA and normal subjects respectively. There was no significant difference between the effects of OIA and normal plasma on PMN adherence.
Linear regression analysis was used to determine if there was any relation between the extent of adherence inhibition induced by the RA plasma and the patients' clinical and immunological status. There were significant negative correlations between the inhibition of adherence and the level of immune complexes (p<001), as measured by the Clq binding assay (Fig. 3) , and the level of IgA rheumatoid factor and immune complexes bearing IgG when measured by the Clq solid phase assay (Table 1 ). There was no correlation between the (3) 43 (4) 14 (4) RA (6) 30 (3) tory action of the RA plasma does not appear to be mediated via the release of cyclo-oxygenase products from endothelial cells. To determine if RA plasma was inducing the release of other products of endothelial cells that might have been modifying the PMN attachment the action of plasma samples from six patients with RA, three patients with OIA, and three normal subjects on PMN adhesion was compared using endothelium and wells of plastic plates (Limbro) incubated with 20% heat inactivated fetal calf serum for one hour at 37°C and rinsed twice with PBS. The RA plasma induced a mean 35% (p<0-05) and 62% (p<0-01) inhibition of adhesion in the endothelium and serum coated plastic assay respectively when compared with the effect of plasma obtained from normal subjects and patients with OIA (Table 2 ). This experiment suggests that the inhibition of adhesion induced by the RA plasma was not mediated through the release of endothelial cell secretory products. EFFECT 37°C . Thereafter, aliquots of the PMN suspension were added to the endothelial cell monolayers. When serum was absent from the culture medium the HAGG induced a mean 33% increase in adhesion (Fig. 4) . In contrast, when 20% autologous sera were added to the assay the HAGG induced a mean 28% inhibition of adhesion.
Discussion
The demonstration that serum 
